Target Name: LOC107986771
NCBI ID: G107986771
Other Name(s): LOC107986771 variant X1 | Uncharacterized LOC107986771, transcript variant X1

LOC107986771: A Promising Protein Target for Disease Treatment

LOC107986771 (LOC107986771 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and pancreas. It is a member of the superfamily of transmembrane protein serpins, which are a type of transmembrane protein that can interact with a wide variety of molecules, including small molecules, ions, and even drugs.

LOC107986771 variant X1 is unique because of its structure. It has 11 transmembrane domains, each of which is characterized by a unique arrangement of amino acids. This arrangement gives the protein a unique 3D structure that allows it to interact with other molecules in a specific way.

One of the most interesting things about LOC107986771 is its potential as a drug target. Because it is expressed in many different tissues of the body, it is a promising candidate for targeting a wide range of diseases. For example, LOC107986771 has been shown to be involved in a number of physiological processes, including blood clotting, inflammation, and stress response. This suggests that it could be a useful target for drugs that are designed to modulate these processes.

In addition to its potential as a drug target, LOC107986771 is also a valuable biomarker. Because it is expressed in many different tissues of the body, it can be used as a protein biomarker for a wide range of diseases. For example, LOC107986771 has been used as a biomarker for a number of cardiovascular diseases, including heart failure, hypertension, and stroke.

LOC107986771 is also a good candidate as a potential therapeutic target for a wide range of diseases. Its unique 3D structure and its involvement in a number of important physiological processes make it a promising candidate for targeting a wide range of diseases.

In conclusion, LOC107986771 (LOC107986771 variant X1) is a protein that is expressed in various tissues of the body and is characterized by its unique 3D structure and its involvement in a number of important physiological processes. As a result, it is a promising candidate for targeting a wide range of diseases, including drug targets and biomarkers. Further research is needed to fully understand its potential and to develop safe and effective therapies that can be used to treat a wide range of diseases.

Protein Name: Uncharacterized LOC107986771, Transcript Variant X1

More Common Targets

LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683